Heralded as the first and only treatment to block a source of hot flashes in menopausal women, recently approved Veozah (fezolinetant) faces patient access challenges.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,